Steve Hoffman
Chief Executive Officer at Tyme, Inc.
Steve Hoffman active positions
| Companies | Position | Start | End |
|---|---|---|---|
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Director/Board Member | 2013-06-30 | - |
| Chief Executive Officer | 2013-06-30 | - |
Career history of Steve Hoffman
Former positions of Steve Hoffman
| Companies | Position | Start | End |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Chief Executive Officer | 2013-12-31 | 2020-11-23 |
| Chairman | 2013-12-31 | 2022-03-20 | |
| Chief Tech/Sci/R&D Officer | 2015-03-04 | 2022-03-20 | |
| Founder | 2011-11-21 | 2022-03-20 | |
| Luminant Biosciences LLC | Chief Executive Officer | 2015-02-28 | 2020-09-30 |
| Chief Tech/Sci/R&D Officer | 2011-08-31 | 2020-09-30 | |
| Founder | 2011-08-31 | 2020-09-30 | |
Mikronite Technologies Group, Inc.
 Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Chief Tech/Sci/R&D Officer | 1992-12-31 | 2006-12-31 |
| Founder | 1992-12-31 | 2006-12-31 |
Statistics
International
| United States | 5 |
Operational
| Chief Executive Officer | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
Sectoral
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a private company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
Mikronite Technologies Group, Inc.
Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Producer Manufacturing |
| Luminant Biosciences LLC |
- Stock Market
- Insiders
- Steve Hoffman
- Experience